Intervention(s)Comparison(s)Intervention favoured
DVTPEMB
Prophylaxis vs no prophylaxis
IPCD/FIDNo prophylaxisNot sig--
GCSNo prophylaxisNot sigNot sig-
Aspirin (high dose)No prophylaxisAsp (HD)Not sig-
UFHNo prophylaxisUFH-No events
LMWHNo prophylaxisNot sig-Not sig
Single prophylaxis vs single
LMWHUFHLMWHNot sigNot sig
Aspirin (High dose)UFHNot sigNot sigNot sig
Double prophylaxis vs single
GCS + aspirinaspirinNot sigNo events
IPCD/FID + GCSGCSNot sigNo events-
UFH + GCSGCSNot sig--
Other Strategies
LMWH + AspUFH + AspLMWH + AspNot sigNot sig
IPCD/FID + GCSUFH + GCSNot sig--
Cost Effectiveness
No cost effectiveness model was completed for this population

The prophylaxis strategy which is significantly more effective in reducing DVT or PE; or resulting in significantly less major bleeding is stated in bold. Not sig - not statistically significant difference; ‘-’ = not reported; no events – nobody in the study had the outcome. MB = Major bleeding

From: 24, Stroke patients

Cover of Venous Thromboembolism
Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Hospital.
NICE Clinical Guidelines, No. 92.
National Clinical Guideline Centre – Acute and Chronic Conditions (UK).
Copyright © 2010, National Clinical Guideline Centre - Acute and Chronic Conditions.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre - Acute and Chronic Conditions to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.